SEARCH

SEARCH BY CITATION

References

  • 1
    Demetris AJ, Todo S, Van Thiel DH, Fung JJ, Iwaki Y, Sysyn G, Ming W, et al. Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. Am J Pathol 1990; 137:667676.MEDLINE
  • 2
    O'Grady JG, Smith HM, Davies SE, Daniels HM, Donaldson PT, Tan KC, Portmann B, et al. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol 1992; 14:104111.MEDLINE
  • 3
    Eason JD, Freeman RB, Rohrer RJ, Lewis WD, Jenkins R, Dienstag J, Cosimi AB. Should liver transplantation be performed for patients with hepatitis B? Transplantation 1994; 57:15881593.MEDLINE
  • 4
    Samuel D, Bismuth A, Mathieu D, Arulnaden JL, Reynes M, Benhamou JP, Brechot C, et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 1991; 337:813815.MEDLINE
  • 5
    Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329:18421847.MEDLINE
  • 6
    Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998; 27:213222.MEDLINE
  • 7
    Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Buschenfelde KH, Neuhaus P, et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 1998; 27:254263.MEDLINE
  • 8
    Lemmens HP, Langrehr JM, Blumhardt G, Lohmann R, Knopp M, Verschl J, Schattenfroh N, et al. Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis. Transplant Proc 1994; 26:36223623.MEDLINE
  • 9
    Langrehr JM, Lemmens HP, Keck H, Lohmann R, Knopp M, Neumann U, Muller AR, et al. Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis. Transplant Proc 1995; 27:12151216.MEDLINE
  • 10
    Grazi GL, Mazziotti A, Sama C, Jovine E, Stefanini F, Paladini R, Rossi R, et al. Liver transplantation in HBsAg-positive HBV-DNA-negative cirrhotics: immunoprophylaxis and long-term outcome. Liver Transplantation and Surgery 1996; 2:418425.MEDLINE
  • 11
    Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology 1996; 24:13271333.MEDLINE
  • 12
    Jurim O, Martin P, Shaked A, Goldstein L, Millis JM, Calquhoun SD, Gitnick G, et al. Liver transplantation for chronic hepatitis B in Asians. Transplantation 1994; 57:13931395.MEDLINE
  • 13
    McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, McCullough CS, Dickson RC, Caldwell SH, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996; 61:13581364.MEDLINE
  • 14
    Benhamou Y, Katlama C, Lunel F, Coutellier A, Dohin E, Hamm N, Tubiana R, et al. Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Ann Intern Med 1996; 125:70512.MEDLINE
  • 15
    Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333:16571661.MEDLINE
  • 16
    Grellier L, Mutimer D, Ahmed M, Brown D, Burroughs AK, Rolles K, McMaster P, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348:12121215.MEDLINE
  • 17
    Markowitz J, Pakrasi A, Hollis P, Martin P, Goldstein L, Busuttil R. Efficacy of lamivudine for prophylaxis and treatment of hepatitis B in liver transplant patients [Abstract]. Hepatology 1996; 24:182A.
  • 18
    Perrillo R, Rakela J, Martin P, Levy G, Schiff E, Wright T, Dienstag J, et al. Lamivudine for hepatitis B after liver transplantation (OLT) [Abstract]. Hepatology 1996; 24:182A.
  • 19
    Tisdale M, Kemp SD, Parry NR, Larder BA. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc Natl Acad Sci U S A 1993; 90:56535656.MEDLINE
  • 20
    Ling R, Mutimer D, Ahmed M, Boxall EH, Elias E, Dusheiko GM, Harrison TJ. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996; 24:711713.MEDLINE
  • 21
    Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DL. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996; 24:714717.MEDLINE
  • 22
    Dienstag JL, Schiff ER, Mitchell M, Gitlin N, Lissoos T, Condreay L, Garrett L, et al. Extended lamivudine retreatment for chronic hepatitis B [Abstract]. Hepatology 1996; 24:188A.
  • 23
    Bartholomew MM, Jansen RW, Jeffers LJ, Reddy KR, Johnson LC, Bunzendahl H, Condreay LD, et al. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997; 349:2022.MEDLINE
  • 24
    Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2:11041108.MEDLINE
  • 25
    Locarnini SA. Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance. Hepatology 1998; 27:294297.MEDLINE
  • 26
    Xiong X, Flores C, Gibbs C, Toole J. Lack of cross-resistance to PMEA for human hepatitis B DNA polymerases which express lamivudine resistance codons [Abstract]. Hepatology 1997; 26:431A.
  • 27
    Tur-Kaspa R, Laub O. Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression system. J Hepatol 1990; 11:3436.MEDLINE
  • 28
    Muller R, Gubernatis G, Farle M, Niehoff G, Klein H, Wittekind C, Tusch G, et al. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991; 13:9096.MEDLINE
  • 29
    Crippin J, Foster B, Carlen S, Borcich A, Bodenheimer H. Retransplantation in hepatitis B—a multicenter experience. Transplantation 1994; 57:823826.MEDLINE
  • 30
    Huang EJ, Wright TL, Lake JR, Combs C, Ferrell LD. Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation. Hepatology 1996; 23:396404.MEDLINE
  • 31
    Lucey MR, Graham DM, Martin P, Di Bisceglie A, Rosenthal S, Waggoner JG, Merion RM, et al. Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation. Gut 1992; 33:13901396.MEDLINE